Joseph Delligatti has been named CEO and chairman of the board of Kelyniam Global, maker of the Cadcam for replication of artificial bone implants, according to a release from Kelyniam Global.
Mr. Delligatti was the director of sales and marketing for Stryker Corp.’s Physiotherapy Associates division from 2005-2007.
He succeeds James Ketner, who will remain on the board of directors of the Little Rock, Ark.-based company.
Read the release on the new Kelyniam Global CEO.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.